Corticotropin releasing factor antagonists
US6403599B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 30, 1996 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Oct 30, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating, preventing or inhibiting a disorder selected from the group consisting of cardiovascular or heart related diseases such as stroke, hypertension, tachycardia, and congestive heart failure, osteoporosis, premature birth, psychosocial dwarfism, stress-induced fever, ulcer, diarrhea, post-operative ileus, and colonic hypersensitivity associated with psychopathological disturbance and stress, comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of the formula or a pharmaceutically acceptable salt thereof, wherein A, B, D, E, Y, Z, R3, R4, and R5 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.